IBDEI0Z3 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17430,1,1,0)
 ;;=1^V44.6
 ;;^UTILITY(U,$J,358.3,17430,1,8,0)
 ;;=8^Urostomy Status NEC
 ;;^UTILITY(U,$J,358.3,17430,2)
 ;;=^295453
 ;;^UTILITY(U,$J,358.3,17431,0)
 ;;=V44.7^^111^1086^3
 ;;^UTILITY(U,$J,358.3,17431,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17431,1,1,0)
 ;;=1^V44.7
 ;;^UTILITY(U,$J,358.3,17431,1,8,0)
 ;;=8^Artificial Vagina Status
 ;;^UTILITY(U,$J,358.3,17431,2)
 ;;=^295455
 ;;^UTILITY(U,$J,358.3,17432,0)
 ;;=V44.8^^111^1086^1
 ;;^UTILITY(U,$J,358.3,17432,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17432,1,1,0)
 ;;=1^V44.8
 ;;^UTILITY(U,$J,358.3,17432,1,8,0)
 ;;=8^Artif Open Status Nec
 ;;^UTILITY(U,$J,358.3,17432,2)
 ;;=^295456
 ;;^UTILITY(U,$J,358.3,17433,0)
 ;;=V44.9^^111^1086^2
 ;;^UTILITY(U,$J,358.3,17433,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17433,1,1,0)
 ;;=1^V44.9
 ;;^UTILITY(U,$J,358.3,17433,1,8,0)
 ;;=8^Artif Open Status Nos
 ;;^UTILITY(U,$J,358.3,17433,2)
 ;;=^295457
 ;;^UTILITY(U,$J,358.3,17434,0)
 ;;=V10.72^^111^1087^19
 ;;^UTILITY(U,$J,358.3,17434,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17434,1,1,0)
 ;;=1^V10.72
 ;;^UTILITY(U,$J,358.3,17434,1,8,0)
 ;;=8^Hx-Hodgkin'S Disease
 ;;^UTILITY(U,$J,358.3,17434,2)
 ;;=^295237
 ;;^UTILITY(U,$J,358.3,17435,0)
 ;;=V10.71^^111^1087^22
 ;;^UTILITY(U,$J,358.3,17435,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17435,1,1,0)
 ;;=1^V10.71
 ;;^UTILITY(U,$J,358.3,17435,1,8,0)
 ;;=8^Hx-Lymphosarcoma
 ;;^UTILITY(U,$J,358.3,17435,2)
 ;;=^295236
 ;;^UTILITY(U,$J,358.3,17436,0)
 ;;=V10.05^^111^1087^5
 ;;^UTILITY(U,$J,358.3,17436,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17436,1,1,0)
 ;;=1^V10.05
 ;;^UTILITY(U,$J,358.3,17436,1,8,0)
 ;;=8^Hx Of Colonic Malignancy
 ;;^UTILITY(U,$J,358.3,17436,2)
 ;;=^295207
 ;;^UTILITY(U,$J,358.3,17437,0)
 ;;=V10.03^^111^1087^17
 ;;^UTILITY(U,$J,358.3,17437,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17437,1,1,0)
 ;;=1^V10.03
 ;;^UTILITY(U,$J,358.3,17437,1,8,0)
 ;;=8^Hx-Esophageal Malignancy
 ;;^UTILITY(U,$J,358.3,17437,2)
 ;;=^295205
 ;;^UTILITY(U,$J,358.3,17438,0)
 ;;=V10.07^^111^1087^10
 ;;^UTILITY(U,$J,358.3,17438,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17438,1,1,0)
 ;;=1^V10.07
 ;;^UTILITY(U,$J,358.3,17438,1,8,0)
 ;;=8^Hx Of Liver Malignancy
 ;;^UTILITY(U,$J,358.3,17438,2)
 ;;=^295209
 ;;^UTILITY(U,$J,358.3,17439,0)
 ;;=V10.06^^111^1087^30
 ;;^UTILITY(U,$J,358.3,17439,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17439,1,1,0)
 ;;=1^V10.06
 ;;^UTILITY(U,$J,358.3,17439,1,8,0)
 ;;=8^Hx-Rectal   Anal Malign
 ;;^UTILITY(U,$J,358.3,17439,2)
 ;;=^295208
 ;;^UTILITY(U,$J,358.3,17440,0)
 ;;=V10.04^^111^1087^7
 ;;^UTILITY(U,$J,358.3,17440,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17440,1,1,0)
 ;;=1^V10.04
 ;;^UTILITY(U,$J,358.3,17440,1,8,0)
 ;;=8^Hx Of Gastric Malignancy
 ;;^UTILITY(U,$J,358.3,17440,2)
 ;;=^295206
 ;;^UTILITY(U,$J,358.3,17441,0)
 ;;=V10.09^^111^1087^8
 ;;^UTILITY(U,$J,358.3,17441,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17441,1,1,0)
 ;;=1^V10.09
 ;;^UTILITY(U,$J,358.3,17441,1,8,0)
 ;;=8^Hx Of Gi Malignancy Nec
 ;;^UTILITY(U,$J,358.3,17441,2)
 ;;=^295210
 ;;^UTILITY(U,$J,358.3,17442,0)
 ;;=V10.01^^111^1087^13
 ;;^UTILITY(U,$J,358.3,17442,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17442,1,1,0)
 ;;=1^V10.01
 ;;^UTILITY(U,$J,358.3,17442,1,8,0)
 ;;=8^Hx Of Tongue Malignancy
 ;;^UTILITY(U,$J,358.3,17442,2)
 ;;=^295203
 ;;^UTILITY(U,$J,358.3,17443,0)
 ;;=V10.02^^111^1087^28
 ;;^UTILITY(U,$J,358.3,17443,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17443,1,1,0)
 ;;=1^V10.02
 ;;^UTILITY(U,$J,358.3,17443,1,8,0)
 ;;=8^Hx-Oral/Pharynx Malg Nec
 ;;^UTILITY(U,$J,358.3,17443,2)
 ;;=^295204
